Status | Study |
Active, not recruiting |
Study Name: Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma Condition: CNS Cancer CNS BRAIN Date: 2007-12-22 Interventions: Drug: temozolomide followed by high dose busulfan and thiotepa Temozolomide 200mg/m2 PO Days 1-5 recycle |
Active, not recruiting |
Study Name: Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma Condition: Central Nervous System Tumors Brain Tumor Date: 2006-11-16 Interventions: Drug: temozolomide Schedule of Temozolomide administration: Temozolomide, 150 mg/m2/d x days 1-7 and 15- |
Completed |
Study Name: Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma Condition: Oligoastrocytoma, Mixed Anaplastic Oligodendroglioma Date: 2006-08-08 Interventions: Drug: Temozolomide p.o.(by mouth), 150 mg/m2/d x days 1-7 |
Terminated |
Study Name: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas Condition: Astrocytoma Glioma Oligodendroglioma Date: 2006-08-03 Interventions: Drug: Irinotecan Hydrochloride (HCI) Treatment |
Recruiting |
Study Name: Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors Condition: Adult Anaplastic Oligodendroglioma Adult Mixed Glioma Date: 2006-03-15 Interventions: Drug: Carboplatin Given IA |
Completed |
Study Name: Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours Condition: Oligodendrogliomas Date: 2005-09-13 |
Completed |
Study Name: Prolonged Daily Temozolomide for Low-Grade Glioma Condition: Glioma Astrocytoma Oligodendroglioma Date: 2005-09-09 Interventions: Drug: Temozolomide Given once daily for 49 days followed by 28 days with no drug for a maximum of a year |
Active, not recruiting |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Condition: Adult Anaplastic Oligodendroglioma Adult Mixed Glioma Date: 2002-11-12 Interventions: Drug: Imatinib Mesylate Given |
Active, not recruiting |
Study Name: Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Condition: Brain and Central Nervous System Tumors Date: 2002-04-09 Interventions: Drug: temozolomide Procedure: neoadjuvant |
Completed |
Study Name: Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma Condition: Brain and Central Nervous System Tumors Date: 1999-11-01 Interventions: Biological: filgrastim Drug: busulfan |